1. Home
  2. AUBN vs IBIO Comparison

AUBN vs IBIO Comparison

Compare AUBN & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Auburn National Bancorporation Inc.

AUBN

Auburn National Bancorporation Inc.

N/A

Current Price

$26.55

Market Cap

88.8M

Sector

Finance

ML Signal

N/A

Logo iBio Inc.

IBIO

iBio Inc.

N/A

Current Price

$1.30

Market Cap

83.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AUBN
IBIO
Founded
1907
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
88.8M
83.5M
IPO Year
1996
2009

Fundamental Metrics

Financial Performance
Metric
AUBN
IBIO
Price
$26.55
$1.30
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.75
AVG Volume (30 Days)
497.0
679.7K
Earning Date
04-28-2026
05-14-2026
Dividend Yield
4.61%
N/A
EPS Growth
13.66
81.71
EPS
1.29
N/A
Revenue
$619,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$20.54
N/A
Revenue Growth
0.81
N/A
52 Week Low
$21.60
$0.77
52 Week High
$28.88
$3.82

Technical Indicators

Market Signals
Indicator
AUBN
IBIO
Relative Strength Index (RSI) 52.43 38.24
Support Level $25.13 $0.98
Resistance Level $26.58 $1.52
Average True Range (ATR) 0.17 0.07
MACD 0.01 -0.01
Stochastic Oscillator 47.50 29.71

Price Performance

Historical Comparison
AUBN
IBIO

About AUBN Auburn National Bancorporation Inc.

Auburn National Bancorp Inc is a bank holding company registered with the Board of Governors of the Federal Reserve System (the Federal Reserve). As a bank holding company, the Company may diversify into a broader range of financial services and other business activities than are currently permitted to the Bank under applicable laws and regulations. The holding company structure also provides greater financial and operating flexibility than is presently permitted to the Bank. The Company's business is conducted through the Bank and its subsidiaries. Although it has no immediate plansto conduct any other business, the Company may engage directly or indirectly in several activities closely related to banking permitted by the Federal Reserve.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: